Eagle Boston Investment Management Inc buys $8,941,592 stake in Chemed Corporation (CHE)

Chemed Corporation (CHE) : Eagle Boston Investment Management Inc scooped up 502 additional shares in Chemed Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 12, 2016. The investment management firm now holds a total of 64,024 shares of Chemed Corporation which is valued at $8,941,592.Chemed Corporation makes up approximately 1.16% of Eagle Boston Investment Management Inc’s portfolio.

Other Hedge Funds, Including , Fisher Asset Management reduced its stake in CHE by selling 622 shares or 0.11% in the most recent quarter. The Hedge Fund company now holds 549,286 shares of CHE which is valued at $77,855,798. Chemed Corporation makes up approx 0.14% of Fisher Asset Management’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in CHE by selling 2,591 shares or 42.76% in the most recent quarter. The Hedge Fund company now holds 3,469 shares of CHE which is valued at $488,851.Independent Portfolio Consultants reduced its stake in CHE by selling 150 shares or 27.78% in the most recent quarter. The Hedge Fund company now holds 390 shares of CHE which is valued at $54,959. Chemed Corporation makes up approx 0.02% of Independent Portfolio Consultants’s portfolio.

Chemed Corporation closed down -2.08 points or -1.47% at $139.66 with 1,04,067 shares getting traded on Tuesday. Post opening the session at $141.77, the shares hit an intraday low of $138.42 and an intraday high of $141.82 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Chemed Corporation reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.08 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.72. The company had revenue of $390.40 million for the quarter, compared to analysts expectations of $393.76 million. The company’s revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 EPS.

Many Wall Street Analysts have commented on Chemed Corporation. Company shares were Reiterated by RBC Capital Mkts on Jul 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 162 from a previous price target of $136 .

Chemed Corporation (Chemed) purchases operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians registered nurses home health aides social workers clergy and volunteers. VITAS and Innovative Hospice Care are trademarks and service marks of VITAS Healthcare Corporation a wholly owned indirect subsidiary of the Company. The Company’s Roto-Rooter segment provides plumbing and drain cleaning services to both residential and commercial customers. The Roto-Rootera trademarks and service marks are used and advertised by Roto-Rooter Corporation a wholly owned indirect subsidiary of the Company. The Company operates through two wholly owned subsidiaries: VITAS Healthcare Corporation and Roto-Rooter Group Inc.

Leave a Reply

Chemed Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Chemed Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.